Articles

Ebola Exposes Global Cold Chain Weakness

Ebola Exposes Global Cold Chain Weakness

In the wake of a significant slowdown of new Ebola cases, the World Health Organization declared that the virus has been suppressed too quickly for relevant data to be gathered on the disease. Is this the result of an effective and fast-acting global medical system, or does it speak to a lack of preparation and a sluggish biologic cold chain?

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com
Regulatory Growing Pains Heat Up Cold Chain

Regulatory Growing Pains Heat Up Cold Chain

Biologics companies face a unique paradox. Inconsistent regulations surrounding their in-transit production one hand, and a Byzantine shipping process on the other, result in clinical delays, and ultimately potential financial losses. Streamlining the cold chain, and aligning the priorities of shippers, handlers, and legislators, are paramount, both to improve the current state of the industry and to future global healthcare.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com